Frédéric Hilezian

6PUBLICATIONS
19CO-AUTHORS
Optical technologyOtorhinolaryngologyPredictive and prognostic markersAutoimmunityRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2025
Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis.

Sarah Demortiere, Natacha Stolowy, Marine Perriguey

|Feb 05, 2025
Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome.

Laura Guttieres, Lea Vannelli, Sarah Demortiere

|Apr 16, 2024
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.

Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet

|Mar 25, 2024
Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.

Sarah Demortiere, Bastien Joubert, Marie Benaiteau

|Aug 21, 2023
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?

Roxane Claverie, Marine Perriguey, Audrey Rico

|Jun 09, 2021
TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis.

Frédéric Hilezian, Adil Maarouf, Clemence Boutiere

Pageof 1